Clinical Indications for Prednisone
Prednisone is indicated for a broad spectrum of inflammatory, autoimmune, allergic, hematologic, neoplastic, and endocrine disorders where its anti-inflammatory and immunosuppressive properties provide therapeutic benefit. The FDA-approved indications encompass over 12 major disease categories, with specific dosing and duration varying by condition 1.
Primary Indication Categories
Endocrine Disorders
- Adrenocortical insufficiency (primary or secondary) - though hydrocortisone or cortisone are first-choice agents
- Congenital adrenal hyperplasia
- Hypercalcemia associated with malignancy
- Nonsuppurative thyroiditis 1
Rheumatic Disorders
Prednisone serves as adjunctive short-term therapy for acute episodes or exacerbations in:
- Rheumatoid arthritis (including juvenile RA, with selected cases requiring low-dose maintenance)
- Psoriatic arthritis
- Ankylosing spondylitis
- Acute gouty arthritis
- Acute and subacute bursitis
- Post-traumatic osteoarthritis 1
Autoimmune Hepatitis
For adults with AIH, predniso(lo)ne at 0.5-1 mg/kg/day (potentially up to 1 mg/kg/day in severe/advanced disease) combined with azathioprine is first-line treatment 2. In acute severe AIH, 0.5 mg/kg/day represents an appropriate starting dose balancing efficacy against infection risk 2. For drug-induced autoimmune-like hepatitis (DI-ALH), predniso(lo)ne 0.5 mg/kg/day with rapid tapering over 1-2 months is recommended after withdrawing the causative agent 2.
Nephrotic Syndrome in Children
Corticosteroid therapy (prednisone or prednisolone) for at least 12 weeks is first-line treatment 3. The recommended regimen is:
- Initial dose: 60 mg/m²/day or 2 mg/kg/day (maximum 60 mg) as single daily dose for 4-6 weeks 3
- Maintenance: 40 mg/m² or 1.5 mg/kg on alternate days (maximum 40 mg) for 2-5 months with tapering 3
For frequently relapsing or steroid-dependent nephrotic syndrome, alternate-day prednisone at the lowest dose maintaining remission is suggested 3.
Minimal Change Disease in Adults
Prednisone 1 mg/kg daily (maximum 80 mg) or 2 mg/kg on alternate days (maximum 120 mg) is recommended 4. The initial high dose should be maintained for minimum 4 weeks if complete remission is achieved, maximum 16 weeks if not 4. After remission, taper slowly over up to 6 months 4.
Allergic and Dermatologic Conditions
Prednisone controls severe or incapacitating conditions including:
- Seasonal/perennial allergic rhinitis
- Bronchial asthma
- Contact dermatitis, atopic dermatitis
- Pemphigus, bullous dermatitis herpetiformis
- Severe erythema multiforme (Stevens-Johnson syndrome)
- Severe psoriasis and seborrheic dermatitis 1
Asthma Exacerbations
For outpatient burst therapy: 40-60 mg daily in single or 2 divided doses for 5-10 days in adults 5. In children: 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days 5. For ED management requiring hospitalization, prednisone 1-2 mg/kg in 2 divided doses (maximum 60 mg/day) until PEF reaches 70% predicted 5.
Respiratory Diseases
- Symptomatic sarcoidosis (20-40 mg daily per guidelines, though recent evidence shows 20 mg may be as effective as 40 mg) 6, 7
- Loeffler's syndrome not manageable by other means
- Berylliosis
- Fulminating/disseminated pulmonary tuberculosis (with concurrent antituberculous therapy)
- Aspiration pneumonitis 1
Ophthalmic Diseases
Severe acute and chronic allergic/inflammatory processes involving the eye:
- Allergic corneal marginal ulcers
- Herpes zoster ophthalmicus
- Anterior segment inflammation
- Diffuse posterior uveitis and choroiditis
- Optic neuritis
- Iritis and iridocyclitis 1
Hematologic Disorders
- Idiopathic thrombocytopenic purpura in adults
- Secondary thrombocytopenia in adults
- Acquired (autoimmune) hemolytic anemia
- Erythroblastopenia (RBC anemia)
- Congenital (erythroid) hypoplastic anemia 1
Neoplastic Diseases
Palliative management of:
- Leukemias and lymphomas in adults
- Acute leukemia of childhood 1
Gastrointestinal Diseases
To manage critical periods in:
- Ulcerative colitis
- Regional enteritis (Crohn's disease) 1
Mast Cell Activation Syndrome
Steroid taper/burst may be useful for refractory signs or symptoms at initial oral dosage of 0.5 mg/kg/day, followed by slow taper over 1-3 months 8. For procedures where mast cell activation has been problematic, 50 mg prednisone given 13 hours, 7 hours, and 1 hour before radiologic/invasive procedures may be helpful 8.
Histoplasmosis Complications
Prednisone 0.5-1.0 mg/kg daily (maximum 80 mg) in tapering doses over 1-2 weeks is recommended for:
- Pericarditis with hemodynamic compromise or unremitting symptoms
- Severe mediastinal lymphadenitis with obstruction
- Severe rheumatologic manifestations 9
Concurrent itraconazole (200 mg once or twice daily for 6-12 weeks) is mandatory when corticosteroids are administered to reduce risk of progressive infection 9.
Critical Contraindications and Precautions
Absolute Contraindication
Systemic fungal infections and known hypersensitivity to components 1.
Major Precautions
- Adrenal suppression risk: Drug-induced secondary adrenocortical insufficiency may persist up to 12 months after discontinuation following prolonged high-dose therapy 1
- Osteoporosis prevention: For anticipated glucocorticoid therapy ≥3 months at ≥5 mg prednisone equivalent daily, initiate calcium/vitamin D supplementation, bisphosphonates if BMD below normal, and lifestyle modifications 10
- Infection risk: Use with extreme caution in patients with latent tuberculosis, strongyloidiasis, or other infections 1
- Ophthalmic monitoring: Baseline and periodic intraocular pressure measurements recommended, especially if therapy exceeds 6 weeks 2, 1
- Growth monitoring: Essential in pediatric patients on prolonged therapy 11
High-Risk Populations
For adults <40 years at low fracture risk, strongly recommend against adding osteoporosis therapy unless receiving high-dose GC (≥30 mg daily for ≥30 days or cumulative ≥5 g over 1 year) 10.
Common Pitfalls to Avoid
- Abrupt discontinuation: Never stop prednisone suddenly after prolonged use - taper gradually to avoid adrenal crisis 1
- Inadequate duration in nephrotic syndrome: Extending full-dose treatment from 4 to 6 weeks reduces 3-month recurrence rates in children 12
- Underdosing in severe disease: In autoimmune hepatitis with severe/advanced disease, doses up to 1 mg/kg/day may be necessary 2
- Missing concurrent antifungal therapy: Always add itraconazole when using corticosteroids for histoplasmosis complications 9
- Ignoring bone protection: Initiate osteoporosis prevention measures early, not after fractures occur 10